AprilBio Co Ltd (397030)

Currency in KRW
26,550
+1,150(+4.53%)
Closed·
397030 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25,00027,000
52 wk Range
19,37076,700
Key Statistics
Bid/Ask
26,500.00 / 26,550.00
Prev. Close
25,400
Open
25,350
Day's Range
25,000-27,000
52 wk Range
19,370-76,700
Volume
202.48K
Average Volume (3m)
336.18K
1-Year Change
29.1971%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
397030 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100,000
Upside
+276.65%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 100,000
(+276.65% Upside)

Earnings

Latest Release
May 15, 2026
EPS / Forecast
9.00 / 45.00
Revenue / Forecast
725.35M / --
EPS Revisions
Last 90 days

397030 Income Statement

Compare 397030 to Peers and Sector

Metrics to compare
397030
Peers
Sector
Relationship
P/E Ratio
−61.7x−19.1x−0.4x
PEG Ratio
0.41−0.390.00
Price/Book
6.4x2.5x2.6x
Price / LTM Sales
860.2x7.9x3.0x
Upside (Analyst Target)
294.5%73.3%51.9%
Fair Value Upside
Unlock4.5%7.2%Unlock

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.12M4.78%26.78B
Other Institutional Investors
5.53M23.62%132.18B
Public Companies & Retail Investors
16.76M71.59%400.64B
Total
23.41M100.00%559.59B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Imm Asset Management7.56%1,770,00042,303,000
Sm-Sino Technology Investment Co., Ltd.4.64%1,087,41025,989,099

People Also Watch

35,450
108320
+1.58%
64,300
241560
+2.55%
101,000
237690
+0.30%
18,320
086450
+0.49%
380,000
128940
+0.53%

FAQ

What Is the AprilBio (397030) Stock Price Today?

The AprilBio stock price today is 26,550 KRW.

What Stock Exchange Does AprilBio Trade On?

AprilBio is listed and trades on the KOSDAQ.

What Is the Stock Symbol for AprilBio?

The stock symbol for AprilBio is "397030."

What Is the AprilBio Market Cap?

As of today, AprilBio market cap is 594.71B KRW.

What Is AprilBio's Earnings Per Share (TTM)?

The AprilBio EPS (TTM) is -444.

From a Technical Analysis Perspective, Is 397030 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has AprilBio Stock Split?

AprilBio has split 1 times.

What is the current trading status of AprilBio (397030)?

As of Aug 05, 2026, AprilBio (397030) is trading at a price of 26,550 KRW, with a previous close of 25,400 KRW. The stock has fluctuated within a day range of 25,000 KRW to 27,000 KRW, while its 52-week range spans from 19,370 KRW to 76,700 KRW.

What Is AprilBio (397030) Price Target According to Analysts?

The average 12-month price target for AprilBio is 100,000 KRW, with a high estimate of 100000 KRW and a low estimate of 100000 KRW. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +276.65% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.